The insurance brokerage firm acquired company’s in Pennsylvania, North Carolina, Mississippi, and Iowa.
PCF Insurance Services announced that it has acquired four new insurance businesses: Ignitist, The Brady Agency, Roseberry Insurance Agency, and The Sinnott Agency.1 These acquisitions will further increase PCF’s presence as a national insurance brokerage firm by expanding its presence in Pennsylvania, North Carolina, Mississippi, and Iowa. According to a press release, PCF has operations in 40 states in the U.S.A.
In a press release, PCF’s chief development officer Brooke K. DeWyze said, “At PCF Insurance, we are committed to accelerated and strategic expansion through M&A—not to be confused with high-volume. Our approach to M&A enables us to grow our operations in key markets—based on our analysis for growth potential and alignment with our current footprint—while ensuring that each new business that we integrate aligns with our long-term vision and enhances our capabilities and specialization in key industry verticals. Our recent acquisitions are a testament to this strategy, providing us with significant opportunities to better serve our clients and expand our presence in strategically important markets."
PCF states that it has an active M&A pipeline and is currently still looking to expand its operations by acquiring profitable businesses. In May, the company announced that it had acquired Encore Advisors in Georgia and All Star Insurance in Texas.2
In a press release issued at the time, DeWyze said, “We are excited to welcome Encore Advisors and All Star Insurance to the PCF family as we continue to expand our footprint and deepen our capabilities. These dynamic teams are an excellent fit for PCF because their specializations and niche markets align well with our growth strategy, with Encore expanding our capabilities for employee benefits solutions and All Star strengthening our collective bench strength in serving the transportation industry."
The company also recently announced in early June that Brandon Gray had been named as chief financial officer.3 He had previously served as the company’s treasurer.
In a press release, PCF CEO Felix Morgan said, “Being in a position to tell our great story on a national stage, expand our company's investment strategies, and leverage our strong position into greater financing opportunities requires strategic leadership and vision. Brandon's strong, successful history in this space has been instrumental as our company raises capital to support of accelerated M&A strategy. Now, as our CFO, we'll leverage his financial acumen to ensure we continue to deliver industry-leading revenue growth as we accelerate our overall growth strategy."
In the same press release, Gray said, “I'm truly honored to serve our company as CFO during this exciting time for our company. PCF is focused on strategic growth through the expansion of our footprint in key geographical markets, while setting and achieving aggressive organic growth goals. I'm proud to serve and work alongside our incredible team as we make strategic advances that support our long-term vision of sustainable growth."
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Recent Developments in Pharmaceutical Validation
November 1st 2024Explore the latest pharmaceutical validation developments with industry experts from Barry-Wehmiller Design Group, Kneat Solutions, and No Deviation. You’ll gain valuable data-driven insights and discover emerging trends from the State of Validation 2024 industry report that are shaping the validation landscape.